Emerald Health Therapeutics (EMHTF) Stock Price, News & Analysis

Company Overview

Emerald Health Therapeutics, Inc. was a Canadian cannabis company headquartered in Victoria, British Columbia. The company focused on cultivating, processing and selling cannabis for medical and adult-use markets in Canada.

Its product offerings historically included dried cannabis, cannabis oils and other cannabis-based products sold through Canadian distribution channels. Emerald Health Therapeutics also held interests in cannabis-related ventures, including a former investment in Pure Sunfarms, a Canadian greenhouse cannabis producer.

The company’s operations and public-market status have changed over time, and current information about its business activities is limited. Historical company materials identified Avtar Dhillon as chairman and R. Chris Wagner as a senior executive.

Key Stats

• Today's Range: $0.03 to $0.04
• 50-Day Range: $0.04 to $0.04
• 52-Week Range: $0.02 to $0.09
• Volume: 1.05 million shs
• Average Volume: 116,962 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: OTCMKTS:EMHTF
• CIK: 1768225
• Web: www.emerald.care
• Phone: (800) 757-3536
• Fax: N/A
• Employees: 110
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A